Caseware UK (AP4) 2023.0.135 2023.0.135 2024-04-302024-04-30truetrue2023-05-01falseNo description of principal activity11The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006. 13327542 2023-05-01 2024-04-30 13327542 2022-05-01 2023-04-30 13327542 2024-04-30 13327542 2023-04-30 13327542 c:Director1 2023-05-01 2024-04-30 13327542 c:RegisteredOffice 2023-05-01 2024-04-30 13327542 d:ComputerEquipment 2023-05-01 2024-04-30 13327542 d:ComputerEquipment 2024-04-30 13327542 d:ComputerEquipment 2023-04-30 13327542 d:ComputerEquipment d:OwnedOrFreeholdAssets 2023-05-01 2024-04-30 13327542 d:Goodwill 2023-05-01 2024-04-30 13327542 d:ComputerSoftware 2024-04-30 13327542 d:ComputerSoftware 2023-04-30 13327542 d:CurrentFinancialInstruments 2024-04-30 13327542 d:CurrentFinancialInstruments 2023-04-30 13327542 d:Non-currentFinancialInstruments 2024-04-30 13327542 d:Non-currentFinancialInstruments 2023-04-30 13327542 d:CurrentFinancialInstruments d:WithinOneYear 2024-04-30 13327542 d:CurrentFinancialInstruments d:WithinOneYear 2023-04-30 13327542 d:Non-currentFinancialInstruments d:AfterOneYear 2024-04-30 13327542 d:Non-currentFinancialInstruments d:AfterOneYear 2023-04-30 13327542 d:ShareCapital 2024-04-30 13327542 d:ShareCapital 2023-04-30 13327542 d:RetainedEarningsAccumulatedLosses 2024-04-30 13327542 d:RetainedEarningsAccumulatedLosses 2023-04-30 13327542 c:FRS102 2023-05-01 2024-04-30 13327542 c:AuditExempt-NoAccountantsReport 2023-05-01 2024-04-30 13327542 c:FullAccounts 2023-05-01 2024-04-30 13327542 c:PrivateLimitedCompanyLtd 2023-05-01 2024-04-30 13327542 2 2023-05-01 2024-04-30 13327542 d:ComputerSoftware d:OwnedIntangibleAssets 2023-05-01 2024-04-30 iso4217:GBP xbrli:pure
Company registration number: 13327542







UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED
30 APRIL 2024


HRD MEDICAL LTD






































img69ac.png                        

 


HRD MEDICAL LTD
 


 
COMPANY INFORMATION


Director
Dr H Gopisetty 




Registered number
13327542



Registered office
St. Davids Chelmsford Road
Hatfield Heath

Bishop's Stortford

Hertfordshire

CM22 7BD




Accountants
Menzies LLP
Chartered Accountants

Richmond House

Walkern Road

Stevenage

Herts

SG1 3QP





 


HRD MEDICAL LTD
 



CONTENTS



Page
Statement of Financial Position
1 - 2
Notes to the Financial Statements
3 - 6


 


HRD MEDICAL LTD
REGISTERED NUMBER:13327542



STATEMENT OF FINANCIAL POSITION
AS AT 30 APRIL 2024

2024
2023
Note
£
£

Fixed assets
  

Intangible assets
 3 
120,000
135,000

Tangible assets
 4 
1,512
2,170

  
121,512
137,170

Current assets
  

Debtors: amounts falling due within one year
 5 
157,422
41,250

Bank and cash balances
  
98,149
87,565

  
255,571
128,815

Creditors: amounts falling due within one year
 6 
(74,643)
(55,711)

Net current assets
  
 
 
180,928
 
 
73,104

Total assets less current liabilities
  
302,440
210,274

Creditors: amounts falling due after more than one year
  
(15,266)
-

  

Net assets
  
287,174
210,274


Capital and reserves
  

Called up share capital 
  
100
100

Profit and loss account
  
287,074
210,174

  
287,174
210,274


Page 1

 


HRD MEDICAL LTD
REGISTERED NUMBER:13327542


    
STATEMENT OF FINANCIAL POSITION (CONTINUED)
AS AT 30 APRIL 2024

The director considers that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of income and retained earnings in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 31 January 2025.




................................................
Dr H Gopisetty
Director

The notes on pages 3 to 6 form part of these financial statements.

Page 2

 


HRD MEDICAL LTD
 


 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 APRIL 2024

1.Accounting policies

 
1.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Section 1A of Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.

The following principal accounting policies have been applied:

 
1.2

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Rendering of services

Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:
the amount of revenue can be measured reliably;
it is probable that the Company will receive the consideration due under the contract;
the stage of completion of the contract at the end of the reporting period can be measured reliably; and
the costs incurred and the costs to complete the contract can be measured reliably.

 
1.3

Interest income

Interest income is recognised in profit or loss using the effective interest method.

 
1.4

Finance costs

Finance costs are charged to profit or loss over the term of the debt using the effective interest method so that the amount charged is at a constant rate on the carrying amount. Issue costs are initially recognised as a reduction in the proceeds of the associated capital instrument.

 
1.5

Borrowing costs

All borrowing costs are recognised in profit or loss in the year in which they are incurred.

 
1.6

Taxation

Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the Company operates and generates income.

Page 3

 


HRD MEDICAL LTD
 


 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 APRIL 2024

1.Accounting policies (continued)

 
1.7

Intangible assets

Intangible assets are initially recognised at cost. After recognition, under the cost model, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

All intangible assets are considered to have a finite useful life. If a reliable estimate of the useful life cannot be made, the useful life shall not exceed ten years.

 The estimated useful lives range as follows:

Goodwill
-
10
years

 
1.8

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using the straight-line method.

Depreciation is provided on the following basis:

Computer equipment
-
20%
on cost

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

 
1.9

Financial instruments

Financial instruments are recognised in the Company's Statement of Financial Position when the Company becomes party to the contractual provisions of the instrument.

 
1.10

Dividends

Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting.


2.


Employees

The average monthly number of employees, including directors, during the year was 1 (2023 - 1).

Page 4

 


HRD MEDICAL LTD
 


 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 APRIL 2024

3.


Intangible assets




Goodwill

£



Cost


At 1 May 2023
150,000



At 30 April 2024

150,000



Amortisation


At 1 May 2023
15,000


Charge for the year on owned assets
15,000



At 30 April 2024

30,000



Net book value



At 30 April 2024
120,000



At 30 April 2023
135,000




4.


Tangible fixed assets





Computer equipment

£



Cost


At 1 May 2023
3,289



At 30 April 2024

3,289



Depreciation


At 1 May 2023
1,119


Charge for the year on owned assets
658



At 30 April 2024

1,777



Net book value



At 30 April 2024
1,512



At 30 April 2023
2,170

Page 5

 


HRD MEDICAL LTD
 


 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 APRIL 2024

5.


Debtors

2024
2023
£
£


Other debtors
149,014
41,250

Tax recoverable
8,408
-

157,422
41,250



6.


Creditors: Amounts falling due within one year

2024
2023
£
£

Bank loans
5,078
-

Corporation tax
40,755
53,494

Other creditors
26,810
217

Accruals and deferred income
2,000
2,000

74,643
55,711



7.


Creditors: Amounts falling due after more than one year

2024
2023
£
£

Bank loans
15,266
-

15,266
-



8.


Related party transactions

At the balance sheet date the director owed £24,914 (2023: the company owed £217 to the director) to the company. The balance can be found within debtors. The balance is being repaid after the year end.

 
Page 6